Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients

L.G. van Vlerken, E.J. Huisman, H. van Soest, G.J. Boland, J.P. Drenth, P.D. Siersema, D.M. Burger, K.J. van Erpecum

Research output: Contribution to journalArticleAcademicpeer-review

Cite this